Rheumatology International

, Volume 36, Issue 10, pp 1431–1437 | Cite as

Pregnancy outcomes in women with childhood-onset and adult-onset systemic lupus erythematosus: a comparative study

  • Miguel Ángel Saavedra
  • Dafhne Miranda-Hernández
  • Antonio Sánchez
  • Sara Morales
  • Pilar Cruz-Domínguez
  • Gabriela Medina
  • Luis Javier Jara
Women Issues

Abstract

To compare the maternal and fetal outcomes between childhood-onset and adult-onset systemic lupus erythematosus (SLE), we reviewed the medical records of SLE pregnant women treated from January 2005 to August 2013. For comparison, patients were allocated to one of the two groups, those pregnant patients with SLE onset before 18 years of age (childhood-onset) and ≥18 years (adult-onset). The patients were evaluated at least once in each trimester and postpartum. Relevant maternal and fetal outcomes were extracted, such as lupus flare, preeclampsia/eclampsia, rate of liveborns, fetal loss (spontaneous abortion and stillbirth), term delivery, preterm birth, neonatal death, low birth weight, low birth weight at term, and congenital malformations. We studied 186 pregnancies (in 180 women), 58 of them had childhood-onset SLE, and the remaining 128 had adult-onset SLE. The rate of maternal and fetal complications was similar in both groups. Multivariate analysis showed that active SLE before pregnancy, primigravida, renal flare, preeclampsia, lupus flare, anticardiolipin antibodies, and low serum complement were associated with an increased risk of poor maternal and fetal outcomes. The diagnosis of childhood-onset had no impact on maternal–fetal outcome. The maternal and fetal outcome in women with childhood-onset SLE is similar to that reported in women with adult-onset SLE. Pregnancy in women with childhood-onset SLE should not be contraindicated if the disease is well controlled.

Keywords

Pregnancy Maternal–fetal outcome Systemic lupus erythematosus Childhood-onset lupus 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Malattia C, Martini A (2013) Paediatric-onset systemic lupus erythematosus. Best Pract Res Clin Rheumatol 27:351–362CrossRefPubMedGoogle Scholar
  2. 2.
    Tucker LB, Uribe AG, Fernández M, Vilá LM, McGwin G, Apte M et al (2008) Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 17:314–322CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Brunner HI, Gladman DD, Ibañez D, Urowitz MD, Silverman ED (2008) Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 58:556–562CrossRefPubMedGoogle Scholar
  4. 4.
    Saavedra Salinas MÁ, Barrera Cruz A, Cabral Castañeda AR, Jara Quezada LJ, Arce-Salinas CA, Álvarez Nemegyei J et al (2015) Mexican College of Rheumatology practical guidelines for the care of pregnant patients with autoimmune rheumatic diseases. Part 1. Reumatol Clin 11:295–304CrossRefPubMedGoogle Scholar
  5. 5.
    Silva CAA, Hilario MO, Febronio MV, Oliveira SK, Almeida RG, Fonseca AR et al (2008) Pregnancy outcome in juvenile systemic lupus erythematosus: a Brazilian multicenter cohort study. J Rheumatol 35:1414–1418PubMedGoogle Scholar
  6. 6.
    Machado CJ (2006) Impact of maternal age on birth outcomes: a population-based study of primiparous Brazilian women in the city of Sao Paulo. J Biosoc Sci 38:523–535CrossRefPubMedGoogle Scholar
  7. 7.
    Figuerêdo ED, Lamy Filho F, Lamy ZC, da Silva AA (2014) Maternal age and adverse perinatal outcomes in a birth cohort (BRISA) from a Northeastern Brazilian city. Rev Bras Ginecol Obstet 36:562–568CrossRefPubMedGoogle Scholar
  8. 8.
    Dennis JA, Mollborn S (2013) Young maternal age and low birth weight risk: an exploration of racial/ethnic disparities in the birth outcomes of mothers in the United States. Soc Sci J 50:625–634CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40:1725CrossRefPubMedGoogle Scholar
  10. 10.
    Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definitive antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306CrossRefPubMedGoogle Scholar
  11. 11.
    Saavedra M, Sánchez A, Morales S, Navarro-Zarza J, Angeles U, Jara L (2015) Primigravida is associated with flare in women with systemic lupus erythematosus. Lupus 24:180–185CrossRefPubMedGoogle Scholar
  12. 12.
    Ruperto N, Hanrahan LM, Alarcón GS, Belmont HM, Brey RL, Brunetta P et al (2011) International consensus for a definition of disease flare in lupus. Lupus 20:453–462CrossRefPubMedGoogle Scholar
  13. 13.
    Silva CA, Avcin T, Brunner HI (2012) Taxonomy for systemic lupus erythematosus with onset before adulthood. Arthritis Care Res 64:1787–1793CrossRefGoogle Scholar
  14. 14.
    Saavedra MA, Cruz-Reyes C, Vera-Lastra O, Romero GT, Cruz-Cruz P, Arias-Flores R, Jara LJ (2012) Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy. Clin Rheumatol 31:813–819CrossRefPubMedGoogle Scholar
  15. 15.
    Imbasciati E, Tincani A, Gregorini G, Doria A, Moroni G, Cabiddu G, Marcelli D (2009) Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant 24:519–525CrossRefPubMedGoogle Scholar
  16. 16.
    Gladman DD, Tandon A, Ibañez D, Urowitz MB (2010) The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J Rheumatol 37:754–758CrossRefPubMedGoogle Scholar
  17. 17.
    Tedeschi SK, Massarotti E, Guan H, Fine A, Bermas BL, Costenbader KH (2015) Specific SLE disease manifestations in the six months prior to conception predict similar manifestations during pregnancy. Lupus 24:1283–1292CrossRefPubMedGoogle Scholar
  18. 18.
    Hersh A, von Scheven E, Yelin E (2011) Adult outcomes of childhood-onset rheumatic diseases. Nat Rev Rheumatol 7:290–295CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Baqai T, Ioannou Y (2012) Comparison of juvenile and adult onset systemic lupus erythematosus. Br J Hosp Med 73:558–563CrossRefGoogle Scholar
  20. 20.
    Saavedra MÁ, Sánchez A, Morales S, Ángeles U, Jara LJ (2015) Azathioprine during pregnancy in systemic lupus erythematosus patients is not associated with poor fetal outcome. Clin Rheumatol 34:1211–1216CrossRefPubMedGoogle Scholar
  21. 21.
    Clark CA, Spitzer KA, Nadler JN, Laskin CA (2003) Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol 30:2127–2132PubMedGoogle Scholar
  22. 22.
    Chakravarty EF, Colon I, Langen ES, Nix DA, El-Sayed YY, Genovese MC, Druzin ML (2005) Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 192:1897–1904CrossRefPubMedGoogle Scholar
  23. 23.
    Clowse ME, Magder LS, Witter F, Petri M (2005) The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52:514–521CrossRefPubMedGoogle Scholar
  24. 24.
    Clowse ME (2007) Lupus activity in pregnancy. Rheum Dis Clin N Am 33:237–252CrossRefGoogle Scholar
  25. 25.
    Buyon JP, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD et al (2015) Predictors of pregnancy outcomes in patients with lupus. A cohort study. Ann Intern Med 163:153–163CrossRefPubMedGoogle Scholar
  26. 26.
    Martínez-Salazar GJ, Grimaldo-Valenzuela PM, Vázquez-Peña GG, Reyes-Segovia C, Torres-Luna G, Escudero-Lourdes GV (2015) Caesarean section: history, epidemiology, and ethics to diminish its incidence. Rev Med Inst Mex Seguro Soc 53:608–615PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Miguel Ángel Saavedra
    • 1
  • Dafhne Miranda-Hernández
    • 1
  • Antonio Sánchez
    • 1
  • Sara Morales
    • 2
  • Pilar Cruz-Domínguez
    • 3
  • Gabriela Medina
    • 4
  • Luis Javier Jara
    • 5
  1. 1.Rheumatology Department, Hospital de Especialidades Dr. Antonio Fraga Mouret, Centro Médico Nacional La RazaInstituto Mexicano del Seguro SocialMexico CityMexico
  2. 2.Perinatology Department, Hospital de Gineco-Obstetricia No. 3, Centro Médico Nacional La RazaInstituto Mexicano del Seguro SocialMexico CityMexico
  3. 3.Division of Investigation, Hospital de Especialidades Dr. Antonio Fraga Mouret, Centro Médico Nacional La RazaInstituto Mexicano del Seguro SocialMexico CityMexico
  4. 4.Clinical Research Unit, Hospital de Especialidades Dr. Antonio Fraga Mouret, Centro Médico Nacional La RazaInstituto Mexicano del Seguro SocialMexico CityMexico
  5. 5.Direction of Education and Research, Hospital de Especialidades Dr. Antonio Fraga Mouret, Centro Médico Nacional La RazaInstituto Mexicano del Seguro SocialMexico CityMexico

Personalised recommendations